(CIDRAP News) A team of European researchers reported yesterday the discovery of a human monoclonal antibody that binds to all types of influenza A viruses, raising the prospect of a new flu treatment and improving the chances of developing a broadly protective or "universal" flu vaccine.
(CIDRAP News) A team of US researchers reported this week that a set of antibodies derived from 2009 H1N1 influenza patients showed an ability to react with a number of other flu strains, strengthening hopes that it will eventually be possible to create a broadly protective flu vaccine.
(CIDRAP News) – The era of cell-based influenza vaccine production in the United States seemed to move closer today as Novartis unveiled its new, nearly billion-dollar manufacturing plant in Holly Springs, N.C., but onshore production and marketing of cell-based vaccines remains a few years away.
(CIDRAP News) This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.
(CIDRAP News) Antibodies gleaned from four Vietnamese patients who survived H5N1 avian influenza were used successfully to prevent and treat H5N1 infection in mice, suggesting that the same approach might be useful in humans, according to a recent report by an international team of researchers.
(CIDRAP News) – The outbreak of H5N1 avian influenza in Asia gives the world its first opportunity to prepare a vaccine in advance for a potential pandemic strain of flu, the World Health Organization (WHO) said today as it convened a meeting of vaccine companies and health officials to consider the challenge.